Literature DB >> 2206580

Treatment of early vocal cord carcinoma with 60Co gamma rays, 8/10 MV x-rays, or 4 MV x-rays--are the results different?

I Izuno, S Sone, M Oguchi, K Kiyono, K Takei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2206580     DOI： 10.3109/02841869009090067

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  5 in total

1.  Definitive radiotherapy for early stage glottic cancer by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger Kai-Cheong Ngan; Foon-Yiu Cheung; Sin-Ming Chow; Yiu-Tung Fu; Joseph Siu-Kei Au; Stephen Chun-Key Law
Journal:  Head Neck Oncol       Date:  2012-05-18

2.  Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger K C Ngan; Sin-Ming Chow; Foon-Yiu Cheung; Yiu-Tung Fu; Joseph S K Au; Stephen C K Law
Journal:  Radiat Oncol       Date:  2011-05-21       Impact factor: 3.481

3.  Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma.

Authors:  Ting Jin; Wei-Han Hu; Li-Bing Guo; Wen-Kuan Chen; Qiu-Li Li; Hui Lin; Xiu-Yu Cai; Nan Ge; Rui Sun; Si-Yi Bu; Xin Zhang; Meng-Yao Qiu; Wei Zhang; Su Luo; Yi-Xin Zhou
Journal:  Chin J Cancer       Date:  2011-07

4.  A multicenter survey of stage T1 glottic cancer treated with radiotherapy delivered in 2.25-Gy fractions in clinical practice: An initial 5-year analysis.

Authors:  Yoshiyuki Itoh; Seiji Kubota; Mariko Kawamura; Yoshihito Nomoto; Takayuki Murao; Kouji Yamakawa; Shunichi Ishihara; Naoki Hirasawa; Akiko Asano; Shigeo Yanagawa; Shinji Naganawa
Journal:  Nagoya J Med Sci       Date:  2016-12       Impact factor: 1.131

Review 5.  Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.

Authors:  Hideya Yamazaki; Gen Suzuki; Satoaki Nakamura; Ken Yoshida; Koji Konishi; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.